National Institute of General Medical Sciences; Notice of Closed Meeting, 55805 [2010-22842]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 177 / Tuesday, September 14, 2010 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Initial Review
Group, Biomedical Research and Research
Training Review Subcommittee A.
Date: November 4–5, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Carole H. Latker, PhD,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health,
Natcher Building, Room 3AN18, Bethesda,
MD 20892. 301–594–2848.
latkerc@nigms.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Dated: September 8, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–22842 Filed 9–13–10; 8:45 am]
BILLING CODE 4140–01–P
jlentini on DSKJ8SOYB1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Environmental
Health Sciences; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
VerDate Mar<15>2010
16:38 Sep 13, 2010
Jkt 220001
hereby given of a meeting of the
Interagency Breast Cancer and
Environmental Research Coordinating
Committee.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Interagency Breast
Cancer and Environmental Research
Coordinating Committee.
Date: September 30–October 1, 2010.
Time: 8:30 a.m. to 3:30 p.m.
Agenda: The purpose of the meeting is to
initiate the work of the Committee, which is
to share and coordinate information on
existing research activities, and to make
recommendations to the National Institutes
of Health and other Federal agencies
regarding how to improve existing research
programs related to breast cancer and the
environment.
Place: JW Marriott, 1313 Pennsylvania
Avenue, NW., Washington, DC 20004.
Contact Person: Gwen W. Collman, PhD,
Acting Director, Division of Extramural
Research and Training, National Institute of
Environmental Health Sciences, 615 Davis
Dr., KEY615/3112, Research Triangle Park,
NC 27709. (919) 541–4980.
collman@niehs.nih.gov.
Any member of the public interested in
presenting oral comments to the committee
should submit their remarks in writing at
least 10 days in advance of the meeting.
Comments in document format (i.e. WORD,
Rich Text, PDF) may be uploaded via the
following Web site: https://www.cmpinc.net/
IBCERCC. Alternatively, comments may be
submitted via e-mail to the Contact Person
listed on this notice. You do not need to
attend the meeting in order to submit
comments.
Interested individuals and representatives
of organizations may submit a letter of intent,
a brief description of the organization
represented, and a short description of the
oral comments you wish to present. Only one
representative per organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. The statement should include the
name, address, telephone number and, when
applicable, the business or professional
affiliation of the interested person. Oral
comments will begin at approximately 4:15
p.m. on Thursday, September 30, 2010.
Although time will not be allotted for
comments on Friday, October 1, 2010,
members of the public are welcome to attend
the entire meeting.
Anyone who wishes to attend the meeting
and/or submit comments to the committee is
asked to RSVP via the following Web site:
https://www.cmpinc.net/IBCERCC. All
comments are delivered to the Contact
Person listed on this notice.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
55805
Estimation— Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
Dated: September 8, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–22830 Filed 9–13–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–N–0001]
Arthritis Advisory Committee; Notice
of Meeting
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
This notice announces a forthcoming
meeting of a public advisory committee
of the Food and Drug Administration
(FDA). The meeting will be open to the
public.
Name of Committee: Arthritis
Advisory Committee.
General Function of the Committee:
To provide advice and
recommendations to the agency on
FDA’s regulatory issues.
Date and Time: The meeting will be
held on November 16, 2010, from 8 a.m.
to 5 p.m.
Location: The Marriott Inn and
Conference Center, University of
Maryland University College, 3501
University Blvd East, Adelphi, MD. The
conference center telephone number is
301–985–7300.
Contact Person: Anuja Patel, Center
for Drug Evaluation and Research, Food
and Drug Administration, 10903 New
Hampshire Ave., WO31–2417, Silver
Spring, MD 20993–0002, 301–796–9001,
FAX: 301–847–8533, email:
anuja.patel@fda.hhs.gov, or FDA
Advisory Committee Information Line,
1–800–741–8138 (301–443–0572 in the
Washington, DC area), code
3014512532. Please call the Information
Line for up-to-date information on this
meeting. A notice in the Federal
Register about last minute modifications
that impact a previously announced
advisory committee meeting cannot
always be published quickly enough to
provide timely notice. Therefore, you
E:\FR\FM\14SEN1.SGM
14SEN1
]]>Agencies
[Federal Register Volume 75, Number 177 (Tuesday, September 14, 2010)]
[Notices]
[Page 55805]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-22842]
[[Page 55805]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of General Medical Sciences; Notice of Closed
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of General Medical
Sciences Initial Review Group, Biomedical Research and Research
Training Review Subcommittee A.
Date: November 4-5, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road, NW., Washington, DC 20015.
Contact Person: Carole H. Latker, PhD, Scientific Review
Officer, Office of Scientific Review, National Institute of General
Medical Sciences, National Institutes of Health, Natcher Building,
Room 3AN18, Bethesda, MD 20892. 301-594-2848. latkerc@nigms.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.375,
Minority Biomedical Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology, Physiology, and
Biological Chemistry Research; 93.862, Genetics and Developmental
Biology Research; 93.88, Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National Institutes of Health, HHS)
Dated: September 8, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-22842 Filed 9-13-10; 8:45 am]
BILLING CODE 4140-01-P
